Study finds jabs cut severe variant COVID disease after one shotA real-world study carried out in Canada has found that COVID-19 vaccines from AstraZeneca, Pfizer/BioNTech and Moderna reduce Share XStudy finds jabs cut severe variant COVID disease after one shothttps://pharmaphorum.com/news/study-finds-jabs-cut-severe-variant-covid-disease-after-one-shot/
UK funds ‘long COVID’ research drive as restrictions easeThe UK government has provided almost £20 million ($27 million) in funding for 15 research projects aiming to Share XUK funds ‘long COVID’ research drive as restrictions easehttps://pharmaphorum.com/news/uk-funds-long-covid-treatment-drive-as-restrictions-ease/
FDA adds warning of rare neurological side effect to J&J COVID jabThe FDA has added a new warning on the Johnson & Johnson COVID-19 vaccine, saying the shot has Share XFDA adds warning of rare neurological side effect to J&J COVID jabhttps://pharmaphorum.com/news/fda-adds-warning-of-rare-neurological-side-effect-to-jj-covid-jab/
UK study raises hopes of long COVID test within monthsA diagnostic test to detect long COVID could be available within six to 12 months, following the discovery Share XUK study raises hopes of long COVID test within monthshttps://pharmaphorum.com/news/uk-study-raises-hopes-of-long-covid-test-within-months/
EMA finds possible link between mRNA COVID jabs and myocarditisThe EU medicines regulator has said that there is some evidence to suggest a possible link between mRNA-based Share XEMA finds possible link between mRNA COVID jabs and myocarditishttps://pharmaphorum.com/news/ema-backs-link-between-mrna-covid-jabs-and-myocarditis/
Israel says Pfizer jab less effective against COVID-19 deltaThe Israeli Ministry of Health has reported data suggesting that the efficacy of the Pfizer/BioNTech COVID-19 vaccine has Share XIsrael says Pfizer jab less effective against COVID-19 deltahttps://pharmaphorum.com/news/israel-says-pfizer-jab-less-effective-against-covid-19-delta/
UK body recommends COVID booster campaign in autumnThe UK’s Joint Committee on Vaccination and Immunisation (JCVI) has recommended that the NHS should start a COVID-19 Share XUK body recommends COVID booster campaign in autumnhttps://pharmaphorum.com/news/uk-body-recommends-covid-booster-campaign-in-autumn/
Mix and match regimen of AZ and Pfizer COVID jabs works wellGiving one dose each of AstraZeneca and Pfizer COVID-19 vaccines provides good protection against the SARS-CoV-2 virus, but Share XMix and match regimen of AZ and Pfizer COVID jabs works wellhttps://pharmaphorum.com/news/mix-and-match-regimen-of-az-and-pfizer-covid-jabs-works-well/
J&J agrees to pay $263m to settle NY opioid claims, exits marketJohnson & Johnson has shaken off another lingering liability claim in the US, agreeing a $263 million settlement Share XJ&J agrees to pay $263m to settle NY opioid claims, exits markethttps://pharmaphorum.com/news/jj-agrees-to-pay-263m-to-settle-ny-opioid-claims-exits-market/
